These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31093272)

  • 1. Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease.
    Yu CC; Jiang T; Yang AF; Du YJ; Wu M; Kong LH
    Neural Plast; 2019; 2019():6856327. PubMed ID: 31093272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Regulation of Amyloid-beta Metabolism in Alzheimer's Disease.
    He C; Huang ZS; Yu CC; Wang HH; Zhou H; Kong LH
    Curr Med Sci; 2020 Dec; 40(6):1022-1030. PubMed ID: 33428129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.
    Mano T; Nagata K; Nonaka T; Tarutani A; Imamura T; Hashimoto T; Bannai T; Koshi-Mano K; Tsuchida T; Ohtomo R; Takahashi-Fujigasaki J; Yamashita S; Ohyagi Y; Yamasaki R; Tsuji S; Tamaoka A; Ikeuchi T; Saido TC; Iwatsubo T; Ushijima T; Murayama S; Hasegawa M; Iwata A
    Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9645-E9654. PubMed ID: 29042514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification.
    De Plano LM; Saitta A; Oddo S; Caccamo A
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early epigenetic changes of Alzheimer's disease in the human hippocampus.
    Blanco-Luquin I; Acha B; Urdánoz-Casado A; Sánchez-Ruiz De Gordoa J; Vicuña-Urriza J; Roldán M; Labarga A; Zelaya MV; Cabello C; Méndez-López I; Mendioroz M
    Epigenetics; 2020 Oct; 15(10):1083-1092. PubMed ID: 32233750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity.
    Bernstein AI; Lin Y; Street RC; Lin L; Dai Q; Yu L; Bao H; Gearing M; Lah JJ; Nelson PT; He C; Levey AI; Mullé JG; Duan R; Jin P
    Hum Mol Genet; 2016 Jun; 25(12):2437-2450. PubMed ID: 27060332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroepigenetics and Alzheimer's Disease: An Update.
    Zusso M; Barbierato M; Facci L; Skaper SD; Giusti P
    J Alzheimers Dis; 2018; 64(3):671-688. PubMed ID: 29991138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of DNA methylation on Tau protein related genes in the brains of patients with Alzheimer's disease.
    Wei X; Du P; Zhao Z
    Neurosci Lett; 2021 Oct; 763():136196. PubMed ID: 34437990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone Modifications in Alzheimer's Disease.
    Santana DA; Smith MAC; Chen ES
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer's Disease.
    Gil L; Niño SA; Guerrero C; Jiménez-Capdeville ME
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
    Liu W; Zhao J; Lu G
    Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
    Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
    Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic regulons in Alzheimer's disease.
    Raval M; Mishra S; Tiwari AK
    Prog Mol Biol Transl Sci; 2023; 198():185-247. PubMed ID: 37225321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
    Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
    J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer's Disease Treatment.
    Song Y; Zhu XY; Zhang XM; Xiong H
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms.
    Stanzione R; Cotugno M; Bianchi F; Marchitti S; Forte M; Volpe M; Rubattu S
    Genes (Basel); 2020 Jan; 11(1):. PubMed ID: 31941075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational modifications of tau protein in Alzheimer's disease.
    Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
    J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.
    Li K; Wei Q; Liu FF; Hu F; Xie AJ; Zhu LQ; Liu D
    Mol Neurobiol; 2018 Apr; 55(4):3021-3032. PubMed ID: 28456942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.